Ventricular Assist Device Market - Forecast(2023 - 2028)

1
Ventricular Assist Device MarketMarket size,
Industry outlook, Market Forecast, Demand
Analysis, Market Share, Market Report 2022-2027
Contact Venkat Reddy sales_at_industryarc.com
(1) 970-236-3677
2
Download PDF Brochure

• Ventricular Assist Device Market size is 1.35 Bn
  in 2019, growing at a CAGR of 11.8 during the
  forecast period 2020-2025. Ventricular Assist
  Device is a mechanical pump used to support heart
  function and blood flow in individuals who have
  weakened hearts or cardiac problems. A
  ventricular assist device (VAD) takes blood from
  a lower chamber of the heart and helps pump it
  into the body and vital organs.
• According to the World Health Organization, an
  estimated 17.9 million people die owing to
  cardiovascular diseases worldwide, each year with
  35 of global deaths and 85 of these
  cardiovascular disease deaths are owing to heart
  attack and stroke. The increase in the prevalence
  of Ventricular Assist Device is driving the
  Ventricular Assist Device Market owing towards
  the increase of manufacturers focusing on
  expanding their pipeline to cater to the demand
  for Ventricular Assist Device treatment.

Inquiry Before Buying
Email sales_at_industryarc.com
3
Download PDF Brochure

• Key Takeaways
• Increased rate of heart attack and stroke leading
  to cardiovascular deaths is set to propel the
  growth of the market.
• Increasing developments in the therapy process
  and increased functional capacity and performance
  is driving factors for the growth of Ventricular
  Assist Device market.
• Europe region is estimated to record the fastest
  growth rate during the forecast period 2020-2025.

Inquiry Before Buying
Email sales_at_industryarc.com
4
Download PDF Brochure
Ventricular Assist Device Market - Segment
Analysis In 2019, Left Ventricular Assist Devices
(LVADs) segment dominated the Ventricular Assist
Device Market in terms of revenue is estimated to
grow at a CAGR of 13.7. Left Ventricular Assist
Devices (LVADs) is implanted during an open-heart
surgery, where it receives blood from the left
ventricle and delivers it to the aorta. It works
along with the patients own heart. It is mostly
given as a treatment option for patients with
end-stage heart failure. Bridge-to-Transplant
(BTT) Therapy is the most used therapy type for
Left Ventricular Assist Devices (LVADs) to
restore the heart failure, eliminating the need
for a transplant abetting towards the markets
growth.
Inquiry Before Buying
Email sales_at_industryarc.com
5
Download PDF Brochure

• Ventricular Assist Device Market Industry
  Outlook 
• Abiomed Inc.,
• BiVACOR Inc,
• Abbott Laboratories,
• Medtronic PLC,
• Terumo Corporation,
• Asahi Kasei Corporation,
• Berlin Heart GmbH,
• Calon Cardio-Technology Ltd.,
• CardiacAssist Technologies,
• Jarvik Heart.

Inquiry Before Buying
Email sales_at_industryarc.com
6
Download PDF Brochure
Ventricular Assist Device Market - Forecast(2022
- 2027) Learn More About the Report _at_
https//www.industryarc.com/Report/16935/ventricul
ar-assist-device-market.html
Inquiry Before Buying
Email sales_at_industryarc.com
7
Download PDF Brochure

• You Can Customize the Report as Per Your Need.
  We have included Some Customization Options
• Company Profile
• Analyst Briefing
• Data Tables
• Key Contacts
• Free Customization
• Purchase Full Report _at_ https//www.industryarc.com
  /purchasereport.php?id16935

Inquiry Before Buying
Email sales_at_industryarc.com
8
Download PDF Brochure
For More Details Contact Venkat
Reddy Contact (1) 970-236-3677 Email
sales_at_industryarc.com Connect with us on LinkedIn
_at_ http//www.linkedin.com/company/industryarc
Contact (1) 970-236-3677
Inquiry Before Buying
Email sales_at_industryarc.com